Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer immunotherapy
8
×
fda
life sciences
national
8
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
8
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
europe blog main
europe top stories
startups
clinical trials
investing
amag pharmaceuticals
gilead sciences
nonalcoholic steatohepatitis
novartis
pfizer
What
roundup
bio
cancer
days
develop
amid
biotech
bombast
caught
coronavirus
debate
discussion
efforts
ipo
life
meso’s
miss
new
pandemic
pfizer’s
presidential
promise
response
science
tuesday’s
vaccine
viewers
abbvie’s
according
acquisitions
ahead
akcea
alliance
announced
arrival
bails
biofourmis
brand
bridgebio
bristol
Language
unset
8
×
Current search:
national
×
" cancer immunotherapy "
×
" san francisco top stories "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More